Biohaven Pharmaceutical's Corporate Majority Round

Biohaven Pharmaceutical raised a round of funding on January 06, 2014. Investors include Portage Biotech.

Biohaven Pharmaceutical (NYSE: BHVN) is a clinical-stage biopharmaceutical company with a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The comp…

Articles about Biohaven Pharmaceutical's Corporate Majority Round: